20年移植结果与无普得尼松维持免疫抑制:一个匹配的对照分析
Lindsey Turner1, David M Vock1, Erika Helgeson1
1Division of Biostatistics and Health Data Science, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
Clinical transplantation
|October 14, 2025
概括
快速停止普得尼松 (RDP) 治疗的脏移植接受者比维持普得尼松 (MP) 治疗者有更好的生存率. 长期结果相似或有所改善,这表明RDP是一个可行的选择.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 免疫抑制疗法是一种免疫抑制疗法.
- 移植医学 移植医学 移植医学
背景情况:
- 对于接受了无普得尼松的免疫抑制的移植患者的长期结果存在担忧.
- 普雷尼松维持疗法 (MP) 是移植后常见的免疫抑制策略.
- 迅速停止使用普得尼松 (RDP) 旨在减轻普得尼松的潜在长期副作用.
研究的目的:
- 为了比较接受RDP和MP的脏移植接受者的20年结果.
- 评估RDP对受体存活率,移植存活率和死亡审查的移植存活率的影响.
- 单独评估活体捐赠者 (LD) 和已故捐赠者 (DD) 移植的结果.
主要方法:
- 追溯队列研究,将RDP受体与MP对照匹配,使用移植受体科学注册表.
- 分析包括从1999年到2009年接受LD和DD脏移植的成年人.
- 匹配的队列:361个DD (RDP) 与1805个MP;763个LD (RDP) 与2289个MP.
主要成果:
- 与MP (p = 0.02) 相比,接受RDP的DD接受者表现出明显更好的接受者生存率.
- 对于DD接受者来说,没有观察到移植存活率或死亡审查的移植存活率的显著差异.
- 对于LD接受者,所有测量结果 (接受者存活率,移植存活率,死亡审查的移植存活率) 在RDP和MP组之间没有显著差异.
结论:
- 接受RDP治疗的脏移植接受者与长期MP接受者相比,长期表现相似或改善.
- RDP是一种安全有效的免疫抑制策略,应该考虑大多数移植接受者.
- 这些发现支持RDP的更广泛采用,以潜在地提高移植后的长期患者福祉.
相关概念视频
Kidney Transplant I: Introduction
297
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
297
Kidney Transplant II: Surgical Procedure
270
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
270
Kidney Transplant III: Nursing Management
286
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
286
Acute Kidney Injury III: Clinical Manifestations
754
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
754
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
154
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
154
Tissue Transplantation
850
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
850


